Skip to content

Rehabilitation of impaired body orientation in space: investigation of responsivity of the Spacecurl as a measuring instrument

Rehabilitation of impaired body orientation in space: investigation of responsivity of the Spacecurl as a measuring instrument - IFB 1b

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003228
Enrollment
20
Registered
2011-11-08
Start date
2012-02-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I69.3 R27 R29.5 R29.3

Interventions

Group 1: 10 patients with unilateral right-hemispherical stroke and pusher symptoms receive 1 conventional physiotherapy unit and 1 Lokomat therapy unit in pseudo-randomized order, i.e. conventional p

Sponsors

Klinikum der Universität München, Campus Großhadern
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with unilateral right-hemispherical stroke and pusher or neglect symptoms - Patient is able to be in upright body position for at least 30 min (for arm 1)

Exclusion criteria

Exclusion criteria: Exclusion criteria for the Spacecurl (arm 1 and 2 affected): • Severe cardiovascular disorders • known thrombosis • known Aneurysms • unstable spine • neurosis / psychosis • advanced pregnancy • body height below 145 cm and over 195 cm or body weight >130 kg Exclusion criteria for the Lokomat therapy (affecting arm 1 - pusher): • orthostatic circulatory disturbance • unstable fractures or fractures sensitive to weightbearing • severe osteoporosis • skin problems in the area of the security cuffs • known pre-existing joint problems (eg arthritis) • significant asymmetries (eg discrepancy of leg length ) • Height below 160 cm and over 190 cm or a body weight >150 kg Exclusion criteria for the GVS-stimulation (concerns arm 2 - neglect): • metal implant(s) in the body • brain tumor(s) • inflammation of the scalp • epilepsy • degenerative or psychiatric disease(s)

Design outcomes

Primary

MeasureTime frame
Measurement of Subjective Postural Vertical (SPV) before and after the respective intervention (Pusher (arm 1): day1 and day 3, Neglect (arm 2): day 1, day 3 and day 5. The SPV is measured with the Spacecurl. The examiner slightly tilts the subject in the Spacecurl (coronal and sagittal plane) and leads him slowly (1.8 °/s) back to the vertical. The subject beckons to the investigator (verbally or by pressing a button) when he feels vertically aligned. He also has the possibility to self-adjust his position to the vertical (magnitude estimation and magnitude production). The degrees are measured on a calibrated scale affixed on the Spacecurl. In addition, they are recorded by a Accelometer, which contains a gyroscope.

Secondary

MeasureTime frame
Measurement of Subjective visual vertical (SVV) and Haptic Subjective Vertica (SHP) before and after the respective intervention (Pusher (arm 1): day 1 and day 3, Neglect (arm 2): day 1, day 3 and day 5). Subjective visual vertical (SVV) The bucket method was evaluated by Zwergal et al. (2009) as an easily performed and reliable bed-side test to measure the SVV. For the assessment the subject sits upright and looks into a bucket. The visual field is completely covered by the edge of the bucket. On the bottom of the bucket is a dark, straight line. The bucket is rotated slowly by the examiner from different starting positions in the direction of zero position. The subject indicates when he determines the dark line as vertical and the investigator reads out the deviation in degrees on a scale on the outside of the bucket. Haptic Subjective Vertical (SHP) The SHP is measured with a stick affixed on a vertical board . The subject turns it with his eyes closed from various starting positions in the position where they guess the stick is vertically. Deviation from the vertical can be read out in degrees on a scale on the board.

Countries

Germany

Contacts

Public ContactJeannine Bergmann

Schoen Klinik Bad Aibling

jbergmann@schoen-kliniken.de+49 (0) 8061-903-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026